Omega Fund V GP Manager, Ltd. 4
4 · Nuvation Bio Inc. · Filed Nov 24, 2021
Insider Transaction Report
Form 4
Omega Fund V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-11-22$9.76/sh−295,000$2,879,200→ 24,857,376 total - Sale
Common Stock
2021-11-23$9.75/sh−36$351→ 24,857,376 total
Footnotes (3)
- [F1]The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.